Failure-to-warn lawsuits over hair loss drug on the rise
Lawsuits over the hair loss drugs Propecia and Proscar have been filed in federal and state courts alleging side effects that include erectile dysfunction, infertility, depression and suicide. The...
View ArticleJailed doctor found guilty in wrongful death suit
Randeep Mann, the former Russellville, Ark. doctor who was sentenced to life in prison after the February 2009 bombing of Arkansas State Medical Board Chair Trent P. Pierce, was found to have caused...
View ArticleReglan most litigated drug of 2011, latest ranking says
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration...
View ArticleSuit alleges Zoloft caused birth defects during pregnancy
A Pennsylvania couple has sued Pfizer, alleging that the drug company’s antidepressant medication Zoloft caused their daughter’s birth defects. Denise Ciccone and Nicholas Ciccone are the parents of...
View ArticleFirst trial pool Chantix case settles before trial
The first trial pool case in a multidistrict litigation against Pfizer’s anti-smoking medication Chantix settled last week, just days before the trial was to begin. Judge Inge P. Johnson of the U.S....
View ArticleWatchdog group: Adverse drug events increase
An independent watch dog group has reported a 23.8 percent increase in the number of reports of serious adverse events associated with the use of various medications during the first quarter of 2012 as...
View ArticleMerck settles suit over illegal Vioxx marketing
Merck & Co. has agreed to pay at least $39 million into a fund to settle a Missouri class action over the marketing of the anti-inflammatory drug Vioxx, according to a tentative settlement...
View ArticleCourt ponders class certification standard in securities fraud case
WASHINGTON – In the second of two cases considering what class action plaintiffs must prove to make it past the certification stage, the justices of the U.S. Supreme Court tackled the issue of whether...
View ArticleFDA stands ground on Pradaxa, but more suits filed
Litigation is moving forward against the makers of Pradaxa. More than 100 suits have been filed and the first cases have been scheduled, despite a recent safety review from the Food and Drug...
View ArticleBiotech co. can sue competitor over product claims
A biotech company could sue a competitor under the Lanham Act for distributing a press release that allegedly made false claims about a drug both companies manufactured and sold, a U.S. District Court...
View Article
More Pages to Explore .....